News + Filings Transactions
|
Heyman Tomas J.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/08/2023 | OptiNose, Inc. | OPTN | Grant | Stock Option (Right to Buy) | 53.5k | $1.18 | $63.1k | | 06/08/2023 |
| 05/31/2023 | EXELIXIS, INC. | EXEL | Grant | Option (right to buy) | 36.4k | $19.28 | $700.9k | | 05/31/2023 |
| 05/31/2023 | EXELIXIS, INC. | EXEL | Grant | | 18.2k | $0.00 | $0 | | 05/31/2023 |
| 05/23/2023 | Invivyd, Inc. | | Grant | Stock Option (Right to Buy) | 50k | $1.70 | $85k | | 05/23/2023 |
| 09/15/2022 | Xilio Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 26.4k | $3.15 | $83.2k | | 09/15/2022 |
| 06/22/2022 | Invivyd, Inc. | | Grant | Stock Option (Right to Buy) | 75k | $3.09 | $231.8k | | 06/22/2022 |
| 06/08/2022 | OptiNose, Inc. | OPTN | Grant | Stock Option (Right to Buy) | 32k | $1.95 | $62.4k | | 06/08/2022 |
| 06/02/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 15k | $8.13 | $122k | | 06/02/2022 |
| 06/09/2021 | OptiNose, Inc. | OPTN | Grant | Stock Option (Right to Buy) | 14.4k | $3.54 | $51.1k | | 06/09/2021 |
| 06/01/2021 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 13k | $26.32 | $342.2k | | 06/01/2021 |
| 12/01/2020 | OptiNose, Inc. | OPTN | Grant | Stock Option (Right to Buy) | 28.9k | $4.05 | $117k | | 12/01/2020 |
| 06/09/2020 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 26k | $25.04 | $651k | | 06/09/2020 |
|